FLI's founders and core team -- Max Tegmark, Meia Chita-Tegmark, Anthony Aguirre, Victoria Krakovna, Richard Mallah, Lucas Perry, David Stanley, and Ariel Conn -- discuss the developments of 2016 they were most excited about, as well as why they're looking forward to 2017.
Li-Lian Ang from Blue Dot Impact discusses how to build a workforce to defend against AI-driven risks, including engineered pandemics, cyber attacks, job disempowerment, and concentrated power, using a defense-in-depth framework for uncertain AI progress.
Physician-scientist Emilia Javorsky argues that curing cancer is limited more by biology’s complexity, data quality, and incentives than by intelligence, and explores realistic uses of AI in drug development, trials, and reducing medical bureaucracy.
Emilia Javorsky explores how AI can realistically aid cancer research, where current hype exceeds evidence, and what changes researchers, policymakers, and funders must make to turn AI advances into real clinical impact.